Greenwich LifeSciences Inc

NASDAQ:GLSI   3:59:50 PM EDT
10.40
+0.80 (+8.33%)
Products, Regulatory

Greenwich LifeSciences Provides Updates On Flamingo-01 Phase III Clinical Trial

Published: 08/03/2022 12:24 GMT
Greenwich LifeSciences Inc (GLSI) - Greenwich Lifesciences Provides Updates on Flamingo-01 Phase Iii Clinical Trial.
Greenwich Lifesciences Provides Updates on Flamingo-01 Phase Iii Clinical Trial.
Greenwich Lifesciences Inc - Continue to Actively Recruit and Prepare Additional US Clinical Sites.
Greenwich Lifesciences Inc - Continuing to Make Progress to Initiate Clinical Sites in Europe.